Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

QNCX holding history

Quince Therapeutics, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

QNCX overviewAll 13F holders of QNCXFull Q2 2026 holdings

Shares (Q2 2026)
3
Value
$55
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of QNCX by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263$55<0.1%−792−99.6%ReducedHolders
Q1 2026795$81<0.1%+500+169.5%AddedHolders
Q4 2025295$988<0.1%00.0%UnchangedHolders
Q3 2025295$481<0.1%00.0%UnchangedHolders
Q2 2025295$487<0.1%00.0%UnchangedHolders
Q1 2025295$392<0.1%00.0%UnchangedHolders
Q4 2024295$552<0.1%00.0%UnchangedHolders
Q3 2024295$229<0.1%00.0%UnchangedHolders
Q2 2024295$221<0.1%−16−5.1%ReducedHolders
Q1 2024311$330<0.1%−2,065−86.9%ReducedHolders
Q4 20232,376$2.50K<0.1%00.0%UnchangedHolders
Q3 20232,376$2.66K<0.1%00.0%UnchangedHolders
Q2 20232,376$3.58K<0.1%00.0%UnchangedHolders
Q1 20232,376$3.71K<0.1%−65−2.7%ReducedHolders
Q4 20222,441$1.56K<0.1%00.0%UnchangedHolders
Q3 20222,441$3.00K<0.1%00.0%UnchangedHolders
Q2 20222,441$5.00K<0.1%+891+57.5%AddedHolders
Q1 20221,550$10.0K<0.1%−76−4.7%ReducedHolders
Q4 20211,626$21.0K<0.1%−514−24.0%ReducedHolders
Q3 20212,140$196.0K<0.1%+904+73.1%AddedHolders
Q2 20211,236$66.0K<0.1%+289+30.5%AddedHolders
Q1 2021947$34.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.